2m 2m 2m 2m 2m 2m 2m
Biolargo (BLGO)
OTC
$0.12+$0.02 (+17.98%)
Price as of Jun 03, 2026- $41.7MMarket Cap
- -43.00%1-Year Change
- ChemicalsIndustry
Biolargo (BLGO)
$0.12+$0.02 (+17.98%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 5.8M -65.59% | 16.8M +37.06% | 12.2M +107.85% | 5.9M +132.48% | |
Cost of Revenue | 3.0M -66.76% | 9.1M +49.19% | 6.1M +100.73% | 3.0M +111.97% | |
Gross Profit | 3.4M -56.63% | 7.9M +27.61% | 6.2M +115.40% | 2.9M +159.02% | |
Sales and Marketing Expense | 11.8M +26.51% | 9.3M +15.44% | 8.1M +19.71% | 6.7M +9.06% | |
Research and Development Expense | -2.6M -10.03% | -2.9M +26.29% | -2.3M +73.01% | -1.3M -3.51% | |
Depreciation and Amortization Expense | 145,000 -6.45% | 155,000 +50.49% | 103,000 +128.89% | 45,000 +125.00% | |
Total Operating Expenses | 18.3M +49.88% | 12.2M +13.51% | 10.7M +30.16% | 8.2M +9.39% | |
Operating Profit | -14.9M +242.99% | -4.3M -5.44% | -4.6M -15.03% | -5.4M -16.25% | |
Interest Income | 200,000 +506.06% | 33,000 N/A | N/A N/A | N/A N/A | |
Interest Expense | -540,000 +1,536.36% | -33,000 -63.74% | -91,000 +71.70% | -53,000 -77.35% | |
Interest Income and Expense and Net | -340,000 N/A | 0 +100.00% | -91,000 +71.70% | -53,000 -77.35% | |
Total Nonoperating Income and Expense | -334,000 +1,987.50% | -16,000 -76.47% | -68,000 -126.36% | 258,000 +156.33% | |
Income before Taxes | -11.8M +390.42% | -2.4M -31.45% | -3.5M -21.66% | -4.5M -36.82% | |
Income Taxes | 0 N/A | 0 N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 14,000 N/A | 0 -100.00% | 394,000 +100.00% | 197,000 +157.60% | |
Net Income | -15.2M +249.41% | -4.3M -6.48% | -4.6M -9.43% | -5.1M -25.56% | |
Net Income from Continuing Operations Applicable to Common | -11.8M +390.42% | -2.4M -31.45% | -3.5M -21.66% | -4.5M -36.82% | |
Basic EPS and Net Income | -0.04 +300.00% | -0.01 -50.00% | -0.02 0.00% | -0.02 -33.33% | |
Diluted EPS and Net Income | -0.04 +300.00% | -0.01 -50.00% | -0.02 0.00% | -0.02 -33.33% | |
Basic Weighted Average Shares | 307.0M +2.96% | 298.1M +4.25% | 286.0M +6.58% | 268.3M +8.53% | |
Diluted Weighted Average Shares | 307.0M +2.96% | 298.1M +4.25% | 286.0M +6.58% | 268.3M +8.53% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.9M +9.44% | 3.5M +0.25% | 3.5M +91.19% | 1.9M +92.41% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 3.9M +9.44% | 3.5M +0.25% | 3.5M +91.19% | 1.9M +92.41% | |
Total Current Assets | 5.1M -28.35% | 7.1M +12.18% | 6.4M +101.78% | 3.2M +75.07% | |
Accumulated Depreciation | 607,000 +31.39% | 462,000 N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 1.6M -5.68% | 1.7M +163.14% | 662,000 +130.66% | 287,000 +370.49% | |
Total Long-Term Assets | 106,000 +11.58% | 95,000 +35.71% | 70,000 -43.55% | 124,000 +79.71% | |
Total Assets | 8.3M -20.95% | 10.5M +28.13% | 8.2M +68.90% | 4.9M +60.70% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.4M +187.04% | 486,000 +50.46% | 323,000 +223.00% | 100,000 -68.15% | |
Total Current Liabilities | 5.1M +91.20% | 2.6M -2.29% | 2.7M +71.95% | 1.6M +14.70% | |
Total Long-Term Debt | 182,000 +4.00% | 175,000 -39.45% | 289,000 +21.94% | 237,000 +31.67% | |
Total Long-Term Liabilities | 1.7M -4.81% | 1.8M +39.91% | 1.3M +1.73% | 1.3M +77.51% | |
Total Liabilities | 6.8M +52.23% | 4.5M +11.34% | 4.0M +40.60% | 2.8M +36.22% | |
Retained Earnings | -161.3M +7.88% | -149.5M +1.63% | -147.1M +2.44% | -143.6M +3.22% | |
Total Stockholders Equity | 4.0M -54.33% | 8.9M +29.32% | 6.8M +40.30% | 4.9M +4.84% | |
Total Shares Outstanding | 317.4M +5.35% | 301.3M +2.84% | 292.9M +5.20% | 278.5M +8.82% | |
Cash Flow | |||||
Cash from Operating Activities | -8.3M +158.80% | -3.2M +35.56% | -2.4M -14.37% | -2.8M -29.85% | |
Capital Expenditures | 46,000 -96.28% | 1.2M +158.37% | 478,000 +76.38% | 271,000 +1,190.48% | |
Cash from Investing Activities | 435,000 +133.03% | -1.3M +175.52% | -478,000 +76.38% | -271,000 +697.06% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 8.2M +85.24% | 4.4M -4.74% | 4.7M +17.77% | 4.0M -6.50% | |
Financials Ratio | |||||
Gross Margin | 47.75% +4.00% | 45.92% -8.74% | 50.32% +3.63% | 48.56% +11.42% | |
Operating Margin | -257.59% +896.92% | -25.84% -31.00% | -37.45% -59.12% | -91.60% -63.98% | |
Return on Assets | -161.38% +247.45% | -46.45% -34.73% | -71.16% -45.36% | -130.24% -24.76% | |
Return on Equity | -235.62% +325.35% | -55.39% -30.15% | -79.30% -26.36% | -107.69% -33.53% | |
Revenue Growth | -65.59% -277.01% | 37.06% -65.64% | 107.85% -18.59% | 132.48% +3,154.41% | |
Current Ratio | 1.01 -62.52% | 2.70 +14.81% | 2.35 +17.34% | 2.00 +52.62% | |
Cash Ratio | 0.77 -42.76% | 1.34 +2.60% | 1.31 +11.19% | 1.17 +67.76% | |
Debt-to-Equity Ratio | 0.39 +422.36% | 0.07 -16.44% | 0.09 +29.38% | 0.07 -34.93% | |
Debt-to-Assets Ratio | 0.19 +201.59% | 0.06 -15.68% | 0.07 +7.49% | 0.07 -57.53% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow